EUVIMEDEUVIMED entdecken
Crossref

Evidence That Long‐Term Treatment Prevents Tissue Oxidative Damage in Patients With Inherited Disorders of the Propionate Pathway

Bianca Gomes Dos Reis iD, Graziela Schmitt Becker iD, Desiree Padilha Marchetti iD, Daniella de Moura Coelho iD, Angela Sitta iD, Moacir Wajner iD, Carmen Regla Vargas iD

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.63893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Bianca Gomes Dos Reis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Análises Clínicas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Oxidative Stress, Amino Acid Metabolism, Inborn Errors, Propionates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundo de Incentivo à Pesquisa e Eventos (FIPE/HCPA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Propionic and methylmalonic acidemias (PAcidemia and MMAcidemia, respectively) are genetic disorders clinically characterized by metabolic decompensation associated with life‐threatening encephalopathic episodes in the neonatal period. Adequate and rapid therapeutic management is essential for patients' survival and prognosis. In this study, a restricted protein diet associated with L‐carnitine (LC) supplementation was shown to decrease mortality and morbidity in patients affected by these disorders probably by decreasing the accumulation of the major metabolites and therefore their toxicity. Since oxidative stress was proposed as a contributing mechanism of tissue damage in PAcidemia and MMAcidemia and LC has potent antioxidant properties, our objective in this work was to investigate the effects of a long‐term therapy consisting of reduced protein intake associated with LC supplementation on oxidative damage markers in patients affected by these diseases. We measured urinary isoprostanes, di‐tyrosine, and oxidized guanine species, which reflect oxidative damage to lipids, proteins, and DNA/RNA, respectively, as well as the concentrations of NO products (nitrate plus nitrite) in patients untreated or submitted to short‐term or a long‐term treatment. Results revealed significant increases of isoprostanes, di‐tyrosine, and oxidized guanine species, as well as a moderate nonsignificant increase of NO levels in the untreated patients, relatively to controls. Furthermore, these altered markers were attenuated after short‐term treatment and normalized after prolonged treatment. In conclusion, data from this work show for the first time that long‐standing treatment of patients with disorders of the propionate pathway can protect against oxidative damage. However, it remains to be elucidated whether oxidative stress identified in this study directly correlates with the clinical conditions of the affected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressAmino Acid Metabolism, Inborn ErrorsPropionatesHumansFemaleMaleChild, PreschoolCarnitineChildInfantPropionic AcidemiaBiomarkersAdolescentDietary Supplements

Stichwörter der Autor:innen

L‐carnitineinborn errors of metabolismmethylmalonic acidemiaoxidative damagepropionic acidemia

Substanzen

PropionatesCarnitineBiomarkers

Autor:innen und Institutionen

  • Departamento de Análises Clínicas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Serviço de Genética Médica, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

ORCID-Profile: Bianca Gomes Dos Reis, Graziela Schmitt Becker, Desiree Padilha Marchetti, Daniella de Moura Coelho, Angela Sitta, Moacir Wajner, Carmen Regla Vargas

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Fundo de Incentivo à Pesquisa e Eventos (FIPE/HCPA)

Zitieren

APA

Dos Reis, B. G., Becker, G. S., Marchetti, D. P., Coelho, D. M., Sitta, A., Wajner, M., & Vargas, C. R. (2025). Evidence That Long‐Term Treatment Prevents Tissue Oxidative Damage in Patients With Inherited Disorders of the Propionate Pathway. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63893

Vancouver

Dos Reis BG, Becker GS, Marchetti DP, Coelho DM, Sitta A, Wajner M, et al. Evidence That Long‐Term Treatment Prevents Tissue Oxidative Damage in Patients With Inherited Disorders of the Propionate Pathway. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63893

BibTeX
@article{DosReis2025,
  author = {Dos Reis, Bianca Gomes and Becker, Graziela Schmitt and Marchetti, Desiree Padilha and Coelho, Daniella de Moura and Sitta, Angela and Wajner, Moacir and Vargas, Carmen Regla},
  title = {Evidence That Long‐Term Treatment Prevents Tissue Oxidative Damage in Patients With Inherited Disorders of the Propionate Pathway},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.63893}
}
Kostenlos starten →